About DrugCard
DrugCard is a company based in Tallinn (Estonia) founded in 2020. DrugCard has raised $288.35 thousand across 3 funding rounds from investors including Google, Farmak and New Nordic Ventures. DrugCard operates in a competitive market with competitors including Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health, among others.
- Headquarter Tallinn, Estonia
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Drugcards Oü
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$288.35 K (USD)
in 3 rounds
-
Latest Funding Round
Not available
-
Investors
Google
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of DrugCard
Unlock access to complete
Funding Insights of DrugCard
DrugCard has successfully raised a total of $288.35K across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in DrugCard
DrugCard has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Google, Farmak and New Nordic Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Seed-stage investments are made in Eastern European enterprise software startups.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
A technology company offering products and services, including search engine, cloud computing, advertising, email, productivity software, and more
|
Locked | Locked | Locked |
Investor details for DrugCard
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DrugCard
Investment portfolio details for DrugCard
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - DrugCard
Detailed financials for DrugCard
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Drugcard Comparisons
Peer comparison for DrugCard
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of DrugCard
DrugCard operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Beijing Dongxie Network, biologit, Sentrx, My Meds & Me and Advera Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-based pharmacovigilance platform is developed for report analysis and monitoring.
|
|
| Locked | Locked | Locked |
AI-based solutions for drug pharmacovigilance are provided.
|
|
| Locked | Locked | Locked |
Specialized pharmacovigilance software and services are developed and provided.
|
|
| Locked | Locked | Locked |
Adverse events and product quality are captured for life sciences.
|
|
| Locked | Locked | Locked |
Provider of a SaaS based regulatory data analysis and pharmacovigilance platform for life science industry
|
Detailed competitors of DrugCard
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Drugcard
Complete news archive for DrugCard
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DrugCard
DrugCard was founded in 2020 and raised its 1st funding round 1 year after it was founded.
DrugCard is headquartered in Tallinn, Estonia.
Dmytro Horilyk is the current CEO of DrugCard.
DrugCard is a funded company, having raised a total of $288.35K across 3 funding rounds to date.
DrugCard was founded in 2020 in Tallinn, Estonia, within the pharmaceutical sector. Software solutions are offered to support pharmacovigilance processes, including legal compliance management, data analysis, and AI-enabled decision-making tools. Pharmacovigilance services are also extended to organizations to aid in regulatory adherence and risk assessment across global operations.
DrugCard's top competitors include biologit, Sentrx and My Meds & Me.
DrugCard has 4 investors. Key investors include Google, Farmak, New Nordic Ventures, and Think Bigger Capital.